150
Participants
Start Date
April 1, 2024
Primary Completion Date
October 1, 2025
Study Completion Date
April 1, 2026
Equistasi®
Four devices will be attached to the skin according the indication of the investigators for 6 hours/day every day except Thursday and Sunday
Sham
Four devices similar to the active one but not able to deliver the microvibration will be applied to the patients
Gabapentin; Pregabalin; Duloxetine; Amitriptyline
Patients will be treated with drugs (gabapentinoids, Serotonin-norepinephrine reuptake inhibitor, tricyclic antidepressants, opioids) according to guidelines.
Federico II University
OTHER